Brief: Vivesto Announces Positive Preclinical Results For Cantrixil In AML
04/11/2025 07:03
Nov 4 (Reuters) - Vivesto AB VIVE.ST: ANNOUNCES POSITIVE PRECLINICAL RESULTS FOR CANTRIXIL IN AML Source text: ID:nMFN4w9xSx Further company coverage: VIVE.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))